Skip to main navigation
Medpace Corporate
  • Careers
  • Investors
  • Investigators
  • Study Participants
  • Blog
  • Japan Site
  • Login
  • About
    About

    Our mission is to accelerate the development of safe and effective medical therapeutics.

    • Company Overview 
    Trusted by Biotech Services & Capabilities Brochure: Trusted by Biotech Read More
    hospital executive meets with medical staff Whitepaper Winning at Your Drug Development Strategy – A Playbook for Emerging Biotechs Read More
    • Full-Service CRO
    • Trusted by Biotech
    • People. Purpose. Passion.
    • Leadership
    • Global Reach
    • Locations
    • Ethics & Compliance
  • CRO
    CRO

    Medpace helps biotechs accelerate the development of their medical therapeutics with a full breadth of services and collaborative model.

    • Services Overview 
    doctor speaking during conference Whitepaper A Collaborative Framework for Achieving Diversity, Equity, and Inclusion (DEI) in Clinical Trial Populations Read More
    Woman Testing Glucose Level With Continuous Glucose Monitor Whitepaper Benefits and Challenges of Continuous Glucose Monitoring (CGM) in Clinical Development Read More
    • Study Start-up
    • Clinical Trial Management
      • Sites & Patients
      • Patient Diversity in Clinical Trials
      • Decentralized Clinical Trials
    • Clinical Monitoring
    • Biostats & Data Management
    • Medical Affairs
    • Clinical Safety & Pharmacovigilance
    • Regulatory Affairs & Medical Writing
    • Quality Assurance
    • Technology
  • Therapeutics
    Therapeutics

    Our therapeutically-focused model gives sponsors early and ongoing insight from medical experts throughout trial design and execution, and facilitates collaboration across specialties to incorporate various medical perspectives and considerations.

    • Our Approach 
    • Request Information 
    Illustration of human body with heart and kidneys highlighted Blog [Webinar] Chronic Kidney Disease: Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials Read More
    data concept art Webinar Successful Approaches from Rare Disease and Cellular and Gene Therapy Product Approvals Read More
    • Therapeutic Depth
      • Autoimmune & Inflammation
      • Cardiovascular
      • Dermatology
      • Endocrine & Metabolic
      • Gastroenterology & Hepatology
      • Hematology & Oncology
      • Infectious Diseases & Vaccines
      • Non-Alcoholic Steatohepatitis
      • Nephrology & Renal Disease
      • Neuroscience
      • Ophthalmology
    • Crossovers
      • Rare Diseases
      • Cell & Gene Therapy
      • Radiation Therapy
      • Women’s Health
      • Pediatrics
      • Medical Device & Diagnostics
  • Labs
    Labs

    Medpace offers comprehensive and fully-integrated central and bioanalytical laboratory services that deliver efficient and streamlined execution.

    • Integrated for Efficiency 
    • Take a Tour 
    Flow Cytometry Webinar Establishing Efficacy with Flow Cytometry-Based Receptor Occupancy Assays Read More
    Liquid Biopsy in Oncology Article The Utility of Liquid Biopsy in Oncology Clinical Trials Read More
    • Central Lab
      • Capabilities
      • Biomarkers
      • Safety Testing
      • Featured Methods
      • Therapeutic Expertise
      • Biorepository Services
      • Accreditations
      • Test Directory
    • Bioanalytical Lab
      • Capabilities
      • Discovery & Development
      • Preclinical Studies
      • PK Studies
      • TK Studies
      • Biomarker Assays
      • ADA Assays
      • Neutralizing Antibody Assays
      • Bioanalytical Assays and Posters
  • Core Labs
    Core Labs

    Medpace Core Labs provide an end-to-end suite of global cardiac safety and imaging services to enhance and expedite biopharmaceutical and medical device development.

    • Request Information 
    nurse listening to heartbeat of senior man Article Expert Insights: Q&A with Dr. Satya Shreenivas, Cardiovascular Expert Read More
    Wearables in DCT Webinar Integrating Wearable Remote Biosensor Technology into Decentralized Clinical Trials Read More
    • Imaging Core Lab
      • Therapeutic Expertise
        • Oncology Imaging
        • Endocrine & Metabolic Imaging
        • NASH/NAFLD Imaging
        • Cardiovascular Imaging
        • Neurology Imaging
        • Dermatologic Imaging
        • Nuclear Imaging & Radiopharmaceuticals
        • DXA Imaging Services
      • Image Quantification Services
    • Cardiovascular & ECG Core Lab
    • Wearable Biosensor Technology
  • Phase I Unit
  • Insights
  • Contact
HomeInvestorsCorporate GovernanceBoard of DirectorsBrian T. Carley

Biography

Skip to content
Investor Relations
  • Overview
  • News Releases
  • Events & Presentations
  • Financials & Filings
    • SEC Filings
    • Annual Reports & Proxy
    • Quarterly Results
    • Annual Stockholders Meeting
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Corporate Responsibility Report
  • Investor Resources
    • Information Request
    • IR Contact
    • Analyst Coverage
    • Email Alerts
  • Investor FAQs
Shareholder Tools
  • Print Page
  • RSS Feeds
  • Email Alerts
Headshot of  Brian T.  Carley

Brian T. Carley

Director

Mr. Carley retired from serving Clubessential Holdings, LLC, a privately held Software as a Service (SaaS) holding company providing member management and payments software, in February 2026. From March 2016 to December 2023, he served as their Senior Vice President and Chief Financial Officer. From January 2024 through December 2024 he served as a full-time consultant and then returned as Interim Chief Financial Officer from June 2025 until January 2026. He previously served as President and Chief Executive Officer of the Cincinnati USA Regional Chamber from 2014 to 2015. From 2002 to 2014, Mr. Carley worked at Deloitte & Touche LLP, where he served as regional and office audit division head and audit partner. Before joining Deloitte & Touche LLP, Mr. Carley was employed by Arthur Andersen LLP from 1976 to 2002. There, he served as office managing partner and audit partner. Mr. Carley also has extensive experience serving as a director for a diverse group of companies, including as a director of Assurex Health, Inc. from 2015 until its sale in August 2016, and as a director and officer of numerous civic and charitable organizations. Mr. Carley currently sits on the board of directors of the following private companies or civic and charitable organizations: TriHealth, Inc. and Cincinnati Works.

Mr. Carley received his Bachelor of Science in Accountancy from the University of Illinois, and he is a retired Certified Public Accountant. Mr. Carley was chosen as a director because of his significant financial, accounting and directorship experience from his background as an audit partner at Deloitte & Touche LLP and Arthur Andersen LLP and his experience serving on boards.
.

Financial Expert
  • Chair of the Audit Committee
  • Member of the Nominating and Governance Committee
Medpace, Inc.
5400 Medpace Way, Cincinnati, Ohio 45227 USA
Toll-free: +1.800.730.5779
Tel: +1.513.579.9911
Social Media Links
  • Facebook
  • LinkedIn
  • YouTube
  • Vimeo
  • © 2026 Medpace Holdings, Inc., All Rights Reserved
  • Privacy Policy
  • Accessibility Statement
  • UK Modern Slavery Act
  • Terms of Use
  • Sitemap